Treatment of severe recurrent hepatitis C after liver transplantation in <scp>HIV</scp> infected patients using sofosbuvir‐based therapy

Abstract

Sofosbuvir-based regimens are safe, well-tolerated and provide high rates of SVR in HCV-HIV co-infected patients with severe recurrence after-liver transplant.